QCM Cayman’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,438
| Closed | -$219K | – | 95 |
|
2022
Q1 | $219K | Buy |
+2,438
| New | +$219K | 0.96% | 50 |
|
2021
Q1 | – | Sell |
-2,965
| Closed | -$417K | – | 321 |
|
2020
Q4 | $417K | Buy |
+2,965
| New | +$417K | 0.43% | 59 |
|
2020
Q2 | – | Sell |
-2,906
| Closed | -$225K | – | 143 |
|
2020
Q1 | $225K | Buy |
+2,906
| New | +$225K | 38.53% | 1 |
|
2016
Q4 | – | Sell |
-3,986
| Closed | -$264K | – | 226 |
|
2016
Q3 | $264K | Buy |
+3,986
| New | +$264K | 0.29% | 63 |
|